Dr. Sumaira Aasi

Latest News
Diseases
Diseases & Conditions

Lung Cancer

Breast Cancer

Hematologic Malignancies

Genitourinary Cancers (GU)

Gynecologic Cancers

Glioma

Gastrointestinal Cancers (GI)
Discover local Gastrointestinal Cancers (GI) resources:

Select your city

Ann Arbor
Miami
Phoenix

Prostate Cancer
Featured Articles

Elahere for Ovarian Cancer: Prevention, Detection & Management of Ocular Adverse Events

Neoadjuvant Immunotherapy in Stage III Melanoma: Improved Outcomes with Response-Driven Approach
Events
Our Mission
Physician Resources

Latest News
Diseases
Diseases
- Lung Cancer
- Breast Cancer
- Hematologic Malignancies
- Genitourinary Cancers (GU)
- Gynecologic Cancers
- Glioma
- Gastrointestinal Cancers (GI)
  Discover local Gastrointestinal Cancers (GI) resources:
  
  Select your city
  
  Select your city
  
  Ann Arbor
  Miami
  Phoenix
- Prostate Cancer
Featured Articles
- Elahere for Ovarian Cancer: Prevention, Detection & Management of Ocular Adverse Events
- Neoadjuvant Immunotherapy in Stage III Melanoma: Improved Outcomes with Response-Driven Approach
Events
Our Mission
Physician Resources
My Account
Sign In
Sign Up
Log Out
SurvivorNet.com

Back to Results

Redwood City, CA

LOCATION OF PRACTICE

Stanford Medicine

MEDICAL Specialty:

Melanoma

NPI Number

1780675181

ABOUT

Sumaira Z. Aasi, MD is a Professor of Dermatology and Director of Mohs and Dermatologic Surgery. Dr. Aasi helped train fellows in Mohs and Micrographic Surgery for over ten years. She has served on the Board of Directors of the American College of Mohs Surgery and is currently serving as President. Her clinical interests include management of high risk nonmelanoma skin cancers, Mohs histopathology, and reconstructive surgery.

Is this you? Claim this Profile

Published Articles

Interrater and Intrarater Reliability of Mohs Surgeons in the Assessment of MART-1 Frozen Section Margins for Melanoma.- 2025 Oct 8

Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma.- 2026 Jan

Risk factors for regional or distant metastatic disease in sebaceous carcinoma: A retrospective cohort study from the National Cancer Data Base.- 2026 Jan

Letter to the Editor: Response to "Frozen Section Mohs: A Hybrid Technique and One Plastic Surgeon's Experience." Annals of Plastic Surgery, April 2025.- 2025 Oct 1

An International Perspective on Mohs Surgical Training.- 2026 Feb 1

Subclinical extension of cutaneous squamous cell carcinoma may predict poor outcomes in immunosuppressed patients treated with Mohs micrographic surgery: A retrospective cohort review.- 2025 Oct

Grading differentiation in cutaneous squamous cell carcinoma: A modified Delphi consensus panel.- 2025 Sep

Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: A multicenter retrospective study.- 2025 Aug

Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.- 2025 Jan

Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA).- 2024 Nov

My Patient Resources

Treatment

Treatment For Basal Cell Carcinoma: Mohs Surgery Removes This Skin Cancer With Smaller Incisions and More Certainty

Terms of Use
Privacy Policy
Contact Us
Advertising Policy

Sign Up for SN Connect

Join SN Connect for access to the latest clinical tools, research updates, and expert insights across specialties

Personalized clinical content tailored to your specialty and patient demographics
Comprehensive treatment guides and case studies for evidence-based care
Real-time updates on therapeutic advancements and expert analyses
Decision support tools to enhance patient care
And more..

Already have an account? Sign In